Uncategorised - European Medical Journal

Interview: Nancy Davidson

I worked in a breast cancer laboratory at the National Cancer Institute (NCI), Bethesda, Maryland, USA, during the summer…

Human Papillomavirus May Increase Risk of Heart Disease Death in Females

A recent study found that South Korean females positive for high-risk human papillomavirus were almost four times as likely to die of atherosclerotic cardiovascular disease, compared with females without HPV infection.

Incidental Zinner Syndrome in Nigeria

Case of Incidental Zinner Syndrome

Zinner syndrome (ZS) is a rare urogenital anomaly characterised by a triad of unilateral renal agenesis, ipsilateral seminal vesicle cyst…

Large Language Model Proven to Provide Accurate Information About Alopecia

According to new research, artificial intelligence platforms like ChatGPT are able to provide more accurate answers to dermatological questions than traditional search engines.

Increased Risk for Melanoma-Associated Death in Patients Who Smoke

According to studies, patients diagnosed with melanoma, who smoke (in particular more than 20 cigarettes daily), were found to have an increased risk for melanoma-associated death.

Membranous Nephropathy and Pulmonary Tuberculosis

Mycobacterium tuberculosis causing glomerulonephritis (GN) is a rare occurrence, and its association has been seldom reported…

Interview: Chia-Chun Chiang

My father, a dedicated neurosurgeon, played a significant role in my choice. He tirelessly shared stories of the lives he had saved…

Photon-Counting CT for Early Detection of Spontaneous Intracranial Hypotension

Research suggests that, in comparison with EID-CT myelograms, photon-counting detector CT myelography could facilitate earlier diagnosis of spontaneous intracranial hypotension, showing higher image quality.

Unlocking Autism Spectrum Disorder – Part 2

Geraldine Dawson discusses datasets, algorithms, and biomarkers in early autism detection.

New Treatment for Liver Cancer May Improve Survival

This research has the potential to alter the global standard of care for patients with hepatocellular carcinoma, which for more than 20 years has been treatment with TACE alone.